COX-2 Inhibitor to Prevent Post-ERCP Pancreatitis

NCT02964403 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

2700

Enrollment

OTHER

Sponsor class

Conditions

Pancreatitis, Acute

Interventions

DRUG: Cox-2
DRUG: Indomethacin

Sponsor

First Affiliated Hospital Xi'an Jiaotong University